We reviewed the long-term outcomes of aortic root replacement at Asan Medical Center and investigated the predictors affecting mortality. Materials and Methods: A retrospective analysis was performed on 225 consecutive adult patients undergoing aortic root replacement with mechanical conduits (n=169), porcine aortic root prosthesis (n=23), or aortic homografts (n=33) from January 1992 to September 2009. The median follow-up duration was 6.1 years (range, 0 to 18.0 years). Results: The porcine root group was older than the other groups (freestyle 55.9±14.3 years vs. mechanical 46.3±14.6 years, homograft 48.1±14.7 years; p=0.02). The mechanical group had the highest incidence of the Marfan syndrome (mechanical 22%, freestyle 4%, homograft 3%; p=0.01). Surgery performed for infective endocarditis was more frequent in the homograft group (mechanical 10%, freestyle 10%, homograft 40%; p＜0.001). The overall 30-day mortality was 5.3% (12/225). Actuarial survival rates in the mechanical, porcine root, and homograft groups were 79.4%, 81.5%, and 83.5% at 5 years and 67%, 61.9%, and 61.1% at 10 years, respectively (p=0.73). By multivariate analysis, preoperative diabetes mellitus, older age, and longer cardiopulmonary bypass time were independent predictors of mortality. Incidence of postoperative complications, including infective endocarditis and thromboembolism were comparable in all of the groups. Conclusion: Aortic root replacement can be safely performed with different types of prostheses as the outcome was not affected by the choice of prosthesis. Further studies are required to assess the long-term durability of biological prostheses.
INTRODUCTION
In 1968, Bentall and DeBono described a technique for complete replacement of the aortic valve and ascending aorta with a composite graft: reimplanting the coronary ostia into the graft with the inclusion technique. The outcome was improved by later technical modifications that paid attention to avoiding tension, torsion, or kinking of the coronary reimplantation sites. There remains a concern about the long-term risk of thromboembolism, anticoagulation-related hemorrhage, endocarditis, and reoperation [1] [2] [3] . Biological prostheses such as homograft, pulmonary autograft, and stentless bioprostheses (porcine root or stentless pericardial valve) have been gaining more attention because they can minimize 
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RESULTS
1) Patient demographics
Preoperative patient characteristics are summarized in Table   1 . The mechanical group had a higher degree of the Marfan syndrome (mechanical 22%, freestyle 4%, homograft 3%; p=0.01). Surgical indications for aortic root replacement differed among the three groups, with homograft aortic root replacement having been performed more frequently for infective endocarditis, while aortic dissection patients more frequently received mechanical valved conduits. However, aortic root replacement was performed for annuloaortic ectasia in similar proportions of the mechanical group, the porcine root group, and the homograft group patients (Table 1) .
2) Surgical results
No differences were observed in the three groups with re- 1 ). Of these patients, 11 patients expired of postoperative cardiogenic shock or hemodynamic instability. The one remaining patient expired due to septic shock. There was no statistically significant difference in 30-day mortality between the types of valves (p=0.86) ( Table 2 ).
3) Long term survival
Actuarial survival rates in the mechanical, porcine root, and homograft groups were 79.4%, 81.5%, and 83.5% at 5 years and 67%, 61.9%, and 61.1% at 10 years, respectively (p=0.73) (Fig. 2) predictors of mortality (Table 3 ).
4) Valve-related complications
Reoperation was required in 26 patients (for valve-root dehiscence, structural valve degeneration, periaortic abscess, and infective endocarditis, respectively). The overall freedom from reoperation rate at 1, 5, and 10 years was 97.5%, 91.6%, and 85.3%, respectively. There were meaningful differences in the reoperation rates of the biologic and mechanical groups (p=0.01). Nine patients (4.0%, or 0.02% per patient year) had endocarditis and fourteen patients (6.2%, or 0.3% per patient-year) experienced episodes of clinically significant thromboembolism (including cerebral infarction).
No differences were observed between groups with regard to the frequency of infective endocarditis (p=0.71) or thromboembolism (p=0.16). Postoperative hemorrhage (including intracerebral hemorrhage) events occurred in 28 patients (12.4%, 0.6% per patient-year), and their incidence was higher in the mechanical group than in the other groups (Table 4) .
DISCUSSION
Aortic root replacement has been the favored surgical procedure for patients with annuloaortic ectasia and other disorders of the ascending aorta that are associated with aortic regurgitation. This technique reduced the risk of recurrent proximal aortic aneurysm [1] and surgical outcomes improved dramatically. The thirty-day mortality for aortic root replace-
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These results are gratifying in light of the high mortality attending untreated ascending aortic aneurysm, dissection, and root infection. The hospital deaths that occurred in our study were similar to others reported in the literature [3] . In other comparable aortic root series, the hospital mortality has ranged between 1.7% and 18%, averaging 7% to 8% in recent studies [2] [3] [4] [5] . Although the mortality rate for root replacement is low, risk factors for death have been identified.
In this series, preoperative DM, an older age, and longer cardiopulmonary bypass time were predictors of death. Surprisingly, the era of operation, previous aortic root operation, and use of hypothermic circulatory arrest were not significant predictors of mortality.
Several clinical studies have confirmed the risk factors for mortality. In 2002, Kouchoukos et al. [6] reported that an older age, preoperative New York Heart Association (NYHA)
class III and IV, non-Marfan status, urgent surgery, longer cardiopulmonary bypass time, and male gender were predictors of mortality. Baumgartner et al. [7] reported that a higher mortality rate in patients with aortic root replacement is closely related to NYHA classification III or IV, male gender, and urgent surgery. There was no in-hospital mortality among 13 patients with Marfan's syndrome in our series. The ten-year survival in this series was similar to other series [3, 8] ; only 60% of the patients who undergo aortic root replacement are expected to live longer than 10 years.
Up to now, the optimal choice of valved conduit for aortic valve replacement remains controversial because of a lack of prospective randomized studies. The mechanical valves offer stable hemodynamic function and longer durability, but they are thrombogenic, and patients who receive them require long-term anticoagulation, with its associated increase in the risk of hemorrhage. Bioprosthetic valves have fewer thromboembolic events and usually do not require anticoagulant agents; however, structural deterioration of the valves reduces their durability. This study represents a large series of aortic root replacements performed with aortic mechanical valve conduits or freestyle conduits or homografts. The first study of this kind, by Byrne et al. [9] , included 231 elective aortic root replacements (mechanical, n=85; biologic, n=136), and concluded that there were no meaningful differences in early or mid-term valve-related outcomes between biologic and mechanical groups. Like prior series [9] , our 6-year postoperative follow-up revealed that the majority of patients were generally doing well in all three groups, and we could not find any meaningful differences regarding overall mortality or freedom from valve-related complications in the three groups.
The relatively high rates of bleeding in the mechanical groups were due largely to our policy of anticoagulant ther- Tyers et al. [13] have noted that patients with bioprostheses were more likely to require valve-related reoperation than were those with mechanical prostheses. However, mortality from reoperation secondary to bioprosthetic aortic struc- Like prior series, our study found that patients in the homograft and the freestyle groups may have had a higher risk of reoperation than those in the mechanical group, but all groups may have similar rates of causes leading to reoperation (valve failure, infective endocarditis, ascending aorta dilatation, and ascending aorta pseudoaneurysm).
The most important limitation of this study is that it is not a prospective, randomized, controlled study but a single-institution retrospective review susceptible to inherent selection biases. The patients in the mechanical group, freestyle group, and homograft group were also very heterogeneous and dissimilar with regard to preoperative characteristics and operative indications. The size of the series is also relatively small, and the extent of follow-up is limited beyond 10 years.
This latter point is quite important, particularly because it is in the 10-to 15-year time interval when most of the reported cases of structural valve degeneration occur in aortic allografts [16] [17] [18] . Therefore, a specific comparison of long-term durability in the mechanical valve conduit, freestyle, homograft conduit aortic root replacement groups would require a longer period of follow-up than provided in this study.
CONCLUSION
Our data suggest that aortic root replacement with a mechanical valve conduit is safe and achieves favorable outcomes similar to those of patients receiving homograft or freestyle valve conduits. When choosing the type of valve in aortic root replacement, it is worth considering a number of patient-specific factors, including age, comorbidities, and the risk of hemorrhage and thromboembolism.
